Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Buy
6,048
+213
+4% +$58.9K 0.04% 255
2025
Q4
$1.61M Buy
5,835
+383
+7% +$107K 0.04% 257
2025
Q3
$1.57M Sell
5,452
-12
-0.2% -$3.55K 0.03% 269
2025
Q2
$1.81M Buy
5,464
+78
+1% +$25.1K 0.04% 251
2025
Q1
$1.77M Buy
5,386
+423
+9% +$127K 0.05% 238
2024
Q4
$1.37M Buy
4,963
+189
+4% +$60.2K 0.04% 261
2024
Q3
$1.65M Buy
+4,774
New +$1.64M 0.04% 248
2021
Q1
Sell
-1,207
Closed -$251K 693
2020
Q4
$251K Buy
+1,207
New +$237K 0.01% 482

Other funds holding CI

Bailard's CI Position: Q1 2026 in Review

Bailard increased its Cigna (CI) stake by 3.7% in Q1 2026, buying an estimated $58.9K and bringing the position to 6,048 shares worth $1.61M. The position accounts for 0.04% of the portfolio, ranked #255.

Bailard first reported a position in CI in Q4 2020 and has held it in 8 quarters since. The position peaked at $1.81M in Q2 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Bailard held 6,048 shares of Cigna worth $1.61M as of Q1 2026.
  • Bailard bought 213 Cigna shares in Q1 2026, an estimated $58.9K.
  • Cigna made up 0.04% of Bailard's portfolio in Q1 2026, its #255 holding.
  • Bailard first reported a position in Cigna in Q4 2020 and has held it in 8 quarters since.
  • Bailard's Cigna position peaked at $1.81M in Q2 2025.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Bailard's 13F filing for Q1 2026, filed 11 May 2026.